CA2762072C — Devices, systems, and methods for medicament delivery
Assigned to kaleo Inc · Expires 2017-08-29 · 9y expired
What this patent protects
An apparatus suitable for training a user in the operation of an autoinjector includes a housing, a movable member, an electronic circuit system, a base, and a safety lock. The housing is associated with the autoinjector. The movable member moves within the housing when the appar…
USPTO Abstract
An apparatus suitable for training a user in the operation of an autoinjector includes a housing, a movable member, an electronic circuit system, a base, and a safety lock. The housing is associated with the autoinjector. The movable member moves within the housing when the apparatus is transitioned from an initial configuration to an activated configuration. The electronic circuit system is coupled to the housing, and includes a first switch and a second switch. The base is configured to move relative to the housing between a first position and a second position, and to actuate the second switch to produce a second instruction. The safety lock engages the movable member and limits movement of the base when the safety lock is coupled to the housing. The safety lock is configured to actuate the first switch when the safety lock is removed from the housing to produce a first instruction.
Drugs covered by this patent
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.